186 filings
Page 3 of 10
6-K
7br 6qae5
4 Aug 21
Current report (foreign)
7:21am
6-K
dyofmi m6
27 Jul 21
AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
7:34am
6-K
fxhalxz86s5kj4dkuz99
25 Jun 21
Current report (foreign)
4:31pm
6-K
h5fz2zcgxjgo0icl q3f
21 May 21
Notice of the Annual General Meeting 2021 To the Shareholders of AC Immune SA 1
8:55am
EFFECT
mybq0
6 May 21
Notice of effectiveness
12:15am
6-K
7b3nhee 0hqj4ym2ao
5 May 21
Current report (foreign)
4:53pm
424B5
3rd2o sh5f
5 May 21
Prospectus supplement for primary offering
4:47pm
CORRESP
s3ejtwl4 wru34
3 May 21
Correspondence with SEC
12:00am
UPLOAD
0b91bai9d1cklneia1ih
30 Apr 21
Letter from SEC
12:00am
F-3
mzh023nmih miiko6itn
28 Apr 21
Shelf registration (foreign)
4:29pm
6-K
foq l7gv5
28 Apr 21
Current report (foreign)
7:11am
6-K
jfrye0ycm dik9pv
31 Mar 21
AC Immune Appoints Experienced Biotech and Investment
4:35pm
6-K
2ap lgkapoewfj2
23 Mar 21
AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook
9:06am
6-K
xp1n48qypg1stv2zc
26 Feb 21
Invitation to the Extraordinary Shareholders' Meeting
6:04am
6-K
pggi883 tcvhaeuj
11 Feb 21
Current report (foreign)
8:22am
6-K/A
mazguv3xccvaf79nthr
23 Nov 20
Current report (foreign) (amended)
4:30pm
6-K
kuf1ak78o8tz
23 Nov 20
Immunotherapy Pioneer Prof. Carl H. June Joins AC Immune’s Board of Directors
12:00am
6-K
apbm85
18 Nov 20
Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer
8:25am
6-K
kdqkg
13 Nov 20
Current report (foreign)
8:03am